Skip to main navigation Skip to search Skip to main content

Topically applied mesoridazine exhibits the strongest cutaneous analgesia and minimized skin disruption among tricyclic antidepressants: The skin absorption assessment

  • Kuo Sheng Liu
  • , Yu Wen Chen
  • , Ibrahim A. Aljuffali
  • , Chia Wen Chang
  • , Jhi Joung Wang*
  • , Jia You Fang
  • *Corresponding author for this work
  • Chia Nan University of Pharmacy and Science
  • China Medical University Taichung
  • Chi-Mei Medical Center
  • King Saud University
  • Chang Gung University

Research output: Contribution to journal › Journal Article › peer-review

17 Scopus citations

Abstract

Tricyclic antidepressants (TCAs) are found to have an analgesic action for relieving cutaneous pain associated with neuropathies. The aim of this study was to assess cutaneous absorption and analgesia of topically applied TCAs. Percutaneous delivery was investigated using nude mouse and pig skin models at both infinite and saturated doses. We evaluated the cutaneous analgesia in nude mice using the pinprick scores. Among five antidepressants tested in the in vitro experiment, mesoridazine, promazine and doxepin showed a superior total absorption percentage. The drug with the lowest total absorption percentage was found to be fluphenazine (<7%) either at an infinite dose or at saturated solubility. The follicular pathway was important for mesoridazine and promazine delivery. Mesoridazine showed stronger skin analgesia than the other TCAs although the in vivo skin absorption of mesoridazine (0.34 nmol/mg) was less than that of promazine (0.80 nmol/mg) and doxepin (0.74 nmol/mg). Mesoridazine had a prolonged duration of pain relief (165 min) compared to promazine (83 min) and doxepin (17 min). The skin irritation test demonstrated an evident barrier function deterioration and cutaneous erythema by promazine and doxepin treatment, whereas mesoridazine caused no obvious adverse effect by topical application for up to 7 days.

Original languageEnglish
Pages (from-to)59-68
Number of pages10
JournalEuropean Journal of Pharmaceutics and Biopharmaceutics
Volume105
DOIs
StatePublished - 01 08 2016

Bibliographical note

Publisher Copyright:
© 2016 Elsevier B.V. All rights reserved.

Keywords

  • Mesoridazine
  • Neuropathic pain
  • Skin
  • Topical delivery
  • Tricyclic depressant

Fingerprint

Dive into the research topics of 'Topically applied mesoridazine exhibits the strongest cutaneous analgesia and minimized skin disruption among tricyclic antidepressants: The skin absorption assessment'. Together they form a unique fingerprint.

Cite this